Shelley B Thunen's Net Worth

$7.54 Million

Estimate Recalculated Nov 11, 2024 07:48AM EST

Who is Shelley B Thunen

Shelley B Thunen has an estimated net worth of $7.54 Million. This is based on reported shares across multiple companies, which include RxSight, Inc., INTRALASE CORP, Restoration Robotics, Inc., AEON Biopharma, Inc., ENDOLOGIX INC /DE/, and LENZ Therapeutics, Inc..

SEC CIK

Shelley B Thunen's CIK is 0001297491

Past Insider Trading and Trends

2024 was Shelley B Thunen's most active year for acquiring shares with 16 total transactions. Shelley B Thunen's most active month to acquire stocks was the month of February. 2024 was Shelley B Thunen's most active year for disposing of shares, totalling 23 transactions. Shelley B Thunen's most active month to dispose stocks was the month of March. 2024 saw Shelley B Thunen paying a total of $1,601,764.24 for 442,615 shares, this is the most they've acquired in one year. In 2007 Shelley B Thunen cashed out on 332,174 shares for a total of $5,413,464.92, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RxSight, Inc.

See remarks
Updated Aug 08, 2024
Form 4
50.00K
Aug 08, 2024
50.00K
Grant
Aug 07
Form 4
$4.34
$71.63K
Jul 16, 2024
38.24K
Options
Jul 15
Form 4
-26.61%
-18.40K
$37.14
-$923.83K
Jul 02, 2024
50.74K
Sale
Jul 01
Form 4
-13.83%
-9.75K
$34.14
-$367.08K
May 02, 2024
69.15K
Sale
May 01
Form 4
-70.42%
-20.00K
$49.90
-$997.95K
Apr 02, 2024
22.09K
Sale
Apr 01
Form 4
92.20K
Mar 06, 2024
92.20K
Grant
Mar 04
Form 4
-12.42%
-10.00K
$35.99
-$407.74K
Mar 05, 2024
98.90K
Sale
Mar 01
Form 4
-16.52%
-25.00K
$29.99
-$778.96K
Feb 07, 2024
154.73K
Sale
Feb 05 - Feb 06
Form 4
-39.85%
-31.77K
$30.43
-$998.05K
Jan 29, 2024
76.36K
Sale
Jan 26
Form 4
-12.64%
-10.00K
$27.42
-$236.43K
Jan 03, 2024
97.50K
Sale
Jan 02
Form 4
-27.12%
-40.00K
$27.47
-$1.26M
Dec 18, 2023
107.50K
Sale
ScheduledDec 15
Form 4
120.00K
Mar 10, 2023
120.00K
Grant
Mar 09
Form 4
98.37K
Aug 02, 2021
98.37K
Grant
Jul 31
Form 3
Jul 29, 2021
48.40K
Showing 14 results

INTRALASE CORP

EVP & CFO
Updated Apr 04, 2007
Form 4
-100.00%
-298.43K
$19.75
-$5.38M
Apr 04, 2007
Disposition
Apr 02
Form 4
$1.44
$21.22K
Apr 02, 2007
32.55K
Options
Mar 29
Form 4
-6.70%
-1.28K
$13.37
$24.83
Mar 30, 2007
17.83K
Options
Mar 28
Form 4
63.00K
May 02, 2006
63.00K
Grant
Apr 28
Form 4
-100.00%
-8.38K
$20.29
-$169.95K
Mar 23, 2006
Sale
ScheduledMar 22
Form 4
-10.66%
-1.00K
$19.35
-$19.35K
Feb 24, 2006
8.38K
Sale
ScheduledFeb 22
Form 4
-79.38%
-36.10K
$19.08
-$688.64K
Feb 24, 2006
9.38K
Sale
ScheduledFeb 22
Form 4
-19.33%
-10.90K
$18.64
-$203.17K
Feb 24, 2006
45.48K
Sale
ScheduledFeb 22
Form 4
30.00K
Apr 28, 2005
30.00K
Grant
Apr 27
Form 3
Oct 06, 2004
56.38K
Showing 10 results

Restoration Robotics, Inc.

Investor
Updated Jun 15, 2018
Form 4
13.71K
Jun 15, 2018
13.71K
Grant
Jun 13
Form 3
Oct 11, 2017
Showing 2 results

AEON Biopharma, Inc.

Investor
Updated Sep 04, 2024
Form 4
132.23K
Sep 04, 2024
132.23K
Grant
Aug 31
Form 4
16.26K
Mar 21, 2024
16.26K
Grant
Mar 19
Form 4
58.85K
Aug 16, 2023
58.85K
Grant
Aug 14
Form 3
Jul 24, 2023
Showing 4 results

ENDOLOGIX INC /DE/

Chief Financial Officer
Updated Oct 21, 2015
Form 4
-68.25%
-36.85K
Oct 21, 2015
17.14K
Disposition
Oct 19
Form 4
3.02%
1.58K
$16.45
-$15.69K
May 26, 2015
54.00K
Grant
May 22
Form 4
4.07%
2.15K
$15.77
-$26.38K
Mar 02, 2015
54.95K
Grant
Feb 27
Form 4
184.92%
34.27K
May 27, 2014
52.80K
Grant
May 22
Form 4
37.62K
$13.85
-$33.02K
Mar 13, 2014
37.62K
Grant
Jan 02 - Mar 11
Form 4
100.00K
Jan 04, 2013
40.00K
Grant
Jan 02
Form 3
Jan 04, 2013
Showing 7 results

LENZ Therapeutics, Inc.

Investor
Updated Mar 25, 2024
Form 4
27.00K
Mar 25, 2024
27.00K
Grant
Mar 21
Form 3
Mar 25, 2024
Showing 2 results